Abhishek Jha Received American Heart Association Postdoctoral Fellowship Award 2026-2027
The American Heart Association (AHA) is a globally recognized nonprofit organization dedicated to advancing cardiovascular, stroke, and brain health through research, education, and advocacy.
With a strong commitment to supporting scientific discovery and the next generation of investigators, AHA funds innovative research and competitive training programs worldwide.
Among these, the AHA Postdoctoral Fellowship Award recognizes promising early-career scientists and provides support for high-impact research that aligns with AHA’s mission to improve and save lives.
Abhishek Jha recently shared news of his latest achievement with Hemostasis Today.
“I am pleased to announce that I have been awarded a two-year American Heart Association Postdoctoral Fellowship (2026–2027).
My funded project, ‘Metabolic reprogramming to enhance hematoma resolution in intracerebral hemorrhage,’ will focus on advancing strategies to improve recovery following hemorrhagic stroke.
I am sincerely grateful to Dr. Anil Chauhan for his mentorship and for supporting my development as a scientist. I also extend my appreciation to my lab colleagues for their collaborative spirit, and to the senior investigators who kindly provided letters of support.
My heartfelt thanks to the American Heart Association and the review committee for recognizing the potential impact of this work and investing in its progress.
Best,
-Abhishek Jha
“The award amount has been kept hidden” – Abhishek Jha noted.
The AHA Postdoctoral Fellowship Award is a highly regarded, peer-reviewed fellowship that provides funding, mentorship, and national recognition to promising postdoctoral researchers in cardiovascular and cerebrovascular science.
For continued coverage and updates, visit Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin